Page last updated: 2024-11-05

thalidomide and ADPKD

thalidomide has been researched along with ADPKD in 2 studies

Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lum, EL1
Huang, E1
Bunnapradist, S1
Pham, T1
Danovitch, G1
Gibbs, PJ1
Friend, PJ1
Darby, CR1

Other Studies

2 other studies available for thalidomide and ADPKD

ArticleYear
Acute Kidney Allograft Rejection Precipitated by Lenalidomide Treatment for Multiple Myeloma.
    American journal of kidney diseases : the official journal of the National Kidney Foundation, 2017, Volume: 69, Issue:5

    Topics: Adrenal Cortex Hormones; Aged; Antilymphocyte Serum; Deprescriptions; Female; Graft Rejection; Human

2017
Renal replacement therapy in a patient with phocomelia.
    Journal of the Royal Society of Medicine, 2003, Volume: 96, Issue:11

    Topics: Adult; Ectromelia; Female; Humans; Kidney Failure, Chronic; Kidney Transplantation; Polycystic Kidne

2003